Cephalon

How Teva, Cephalon compare

How Teva, Cephalon compare

Yahoo/AP

Teva to Buy Cephalon for $6.8 Billion, Topping Valeant Bid

Teva to Buy Cephalon for $6.8 Billion, Topping Valeant Bid

Bloomberg

EU probes whether deal to keep generic Provigil off European market broke competition rules

EU probes whether deal to keep generic Provigil off European market broke competition rules

Yahoo/AP

Valeant Pharmaceuticals Responds to Cephalon Board's Letter

Valeant Pharmaceuticals Responds to Cephalon Board's Letter

Bradenton Herald, FL

Cephalon finds it's not so easy being a middle fish

Cephalon finds it's not so easy being a middle fish

Philadelphia Inquirer, PA

Valeant could raise Cephalon bid if it saw books

Valeant could raise Cephalon bid if it saw books

Reuters

Cephalon Wins Order in Patent Suit Delaying Sales of Generic Form of Amrix

Cephalon Wins Order in Patent Suit Delaying Sales of Generic Form of Amrix

Bloomberg

Cephalon Recommends Shareholders Reject Valeant Nominees

Cephalon Recommends Shareholders Reject Valeant Nominees

Yahoo

Valeant CEO Spurns Drug Research for Deals With Cephalon Fight

Valeant CEO Spurns Drug Research for Deals With Cephalon Fight

Bloomberg

Cephelon rejects Valeant takeover offer

Cephelon rejects Valeant takeover offer

Marketwatch